Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Phenylketonuria

Congenital Malformations and Chromosomal Abnormalities

Phenylketonuria is an inherited disorder of metabolism in which the body cannot properly break down the amino acid phenylalanine, found in many protein-containing foods. If left untreated, the resulting buildup of phenylalanine can cause intellectual disability, seizures, behavioral problems, and other mental disorders, along with a distinctive musty odor and lighter skin than would otherwise be expected. Because the condition can be managed through a carefully controlled diet if identified early, many countries screen newborns for it routinely.

Facts
Classification
Body System
Integumentary System 1
Body System
Cardiovascular System 1
ICD-10 Chapter
XVII: Congenital Malformations, Deformations and Chromosomal Abnormalities 2
Communicable or Non-communicable
Non-Communicable 3
Transmission Route
Non-Transmissible 3
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
First Described
1934 4
Connections

Treated By

Sources
1. Wikipedia: Phenylketonuria
Wikipedia
  • Phenylketonuria is an inherited genetic disorder.
  • Lead section, body-system statement
    It may also result in a musty smell and lighter skin.
  • Lead section, body-system statement (cardiovascular)
    A baby born to a mother who has poorly treated PKU may have heart problems, a small head, and low birth weight.
View the Source
2. Wikipedia: ICD-10
WikipediaList of chapters, Chapter XVII
Quote, List of chapters, Chapter XVII
Congenital malformations, deformations and chromosomal abnormalities
View the Source
3. Wikipedia: Non-communicable disease
Wikipedia
  • Lead section, transmission-route statement (inferred from disease-category)
    Down syndrome and Cystic fibrosis.
  • Inherited/genetic diseases section
    Down syndrome and Cystic fibrosis.
View the Source
4. Phenylketonuria (Wikipedia)
Disease discovered in 1934 by Ivar Asbjorn Folling, article introView the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.